The "Global Muscle Stimulator Market" is predicted to reach at a high CAGR of 3.9% during the forecast period (2022-2029).
Muscle stimulator is the elicitation of muscle contraction using electric impulses. It has received an increasing amount of attention in the last few years for many reasons: it can be utilized as a strength training tool for healthy subjects and athletes; it could be used as a rehabilitation and preventive tool for partially or immobilized patients; it could be utilized as a testing tool for evaluating the neural and muscular function in vivo; it could be used as a post-exercise recovery tool for athletes. The market is predicted to grow due to the rising popularity of sports advanced fitness products in the market and increased preference by physiotherapists for treating patients with accident injuries, occupational injuries etc.
Source: DataM Intelligence Analysis (2020)
The muscle stimulator market growth is driven by advancement in technological medical devices and its significance in sports medicine on pain management therapies. Also, an increased number of musculoskeletal disorders among individuals is further predicted to boost the muscle stimulator market.
The rise in geriatrics across the globe is likely to rise the market with an increase in the number of muscle ailments in older adults.
The high cost of the muscle stimulator is likely to hinder the market growth.
The high costs of muscle stimulators motivate the customers to prefer alternative therapies such as acupuncture, aroma Modality and yoga. The lack of knowledge and guidelines regarding the use of muscle stimulators restrained the muscle stimulator market.
A recent analysis of Global Burden of Disease (GBD) data showed that approximately 1.71 billion people globally have musculoskeletal conditions. While the prevalence of musculoskeletal conditions varies by age and diagnosis, people of all ages worldwide are affected. High-Income countries are the most affected in terms of people - 441 million, followed by countries in the WHO Western Pacific Region with 427 million and South-East Asia Region with 369 million.
COVID-19 Impact Analysis
The need for lifesaving medical devices is unlike anything in the healthcare sector with the onset of the COVID-19 pandemic. The muscle stimulating devices are seeing a rise in demand as a significant number of patients with an extended stay in ICU due to COVID-19 are likely develop ICU-acquired weakness.
Based on product Type, the muscle stimulator market is divided into Neuromuscular Electrical Stimulation, Functional Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Interferential and other product Types.
Transcutaneous Electrical Nerve Stimulation dominated the market in 2019
Transcutaneous Electrical Nerve Stimulation is estimated to be the fast-growing segment during the forecast period owing to increasing cases of strokes and spinal cord injuries.
The muscle stimulator market is classified into portable, handheld, and tabletop based on Modality.
Portable stimulators dominated the muscle stimulator market
Owing to the ease of carrying them while traveling, this segment is anticipated to grow in the forecast period. And the launch of different innovative portable devices by companies is also a reason for its domination in the market.
The market is segmented into pain management, neurological disorders, musculoskeletal disorders, and others based on applications.
The pain management segment dominated the market. Due to increasing chronic and acute pain cases, cancer patients' need for pain management therapies is the major for driving its growth in the forecast period.
The muscle stimulator market is classified into hospitals, physioModality clinics, sports clinics, and home care based on end-user.
North America region holds the largest market share muscle stimulator market.
The North American muscle stimulator market is estimated to hold the largest market among all regions during the forecast period, followed by Europe. The USA is expected to hold the highest market in this region due to several cases related to musculoskeletal disorders.
The Asia-Pacific is anticipated to grow its market in the forecast period with increasing awareness of health and fitness and a growing population of patients with muscle injuries and disorders.
Latin America is expected to show a steady CAGR during the forecast period due to the increasing number of people who opt for this device to increase government initiatives for the market.
The Middle East and Africa have a minor share in the muscle stimulation devices market.
Source: DataM Intelligence Analysis (2020)
Some of the key players contributing to the growth of the market include Omron Corporation, R.S. Medical Inc., Neurometrix Inc., Zynex Inc., and DJO Global Inc.,
DJO Global, Inc
Overview: DJO is a medical device company that produces various orthopedic products for rehabilitation, pain mana,gement and phyModificationdality. It has multiple divisions, including Bracing & Supports, Surgical, Footcare, Healthcare Solutions, Recovery, and Consumer. DJO began in 1978 as DonJoy, a small company founded in a Carlsbad, California garage by the Philadelphia Eagles offensive line captain, Mark Nordquist and a local lawyer, Ken Reed.
Product Portfolio: DJO Global is a global developer, manufacturer, and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health, and pain management. The product portfolio highlights innovative Aircast®, Exos and ProCare® offerings.
Critical Development: In November 2018, DJO Global partnered with SirenMD to become the exclusive sales representative for SirenMD's sports team market.
The Muscle Stimulator market report would provide access to an approx
Get your free sample proposal with a single click!